Danske Bank A S grew its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 9.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 75,605 shares of the company’s stock after purchasing an additional 6,505 shares during the quarter. Danske Bank A S’s holdings in Astera Labs were worth $26,913,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in ALAB. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth approximately $25,000. GK Wealth Management LLC acquired a new position in Astera Labs during the 3rd quarter valued at approximately $29,000. Archer Investment Corp acquired a new position in Astera Labs during the 2nd quarter valued at approximately $30,000. Signature Equity Partners LLC grew its stake in Astera Labs by 1,680.0% during the 3rd quarter. Signature Equity Partners LLC now owns 89 shares of the company’s stock worth $32,000 after buying an additional 84 shares during the last quarter. Finally, Transamerica Financial Advisors LLC bought a new position in Astera Labs during the 2nd quarter worth $35,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on ALAB shares. Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. Morgan Stanley boosted their price target on shares of Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a report on Wednesday, November 4th. Barclays upped their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Finally, Jefferies Financial Group increased their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $320.85.
Check Out Our Latest Report on Astera Labs
Astera Labs Price Performance
Shares of ALAB stock opened at $202.34 on Tuesday. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market capitalization of $35.36 billion, a price-to-earnings ratio of 99.91 and a beta of 3.85. The business has a 50 day simple moving average of $292.10 and a 200 day simple moving average of $257.26.
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.13. The firm had revenue of $584.90 million for the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The firm’s revenue for the quarter was up 153.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 2.99 EPS for the current fiscal year.
Insider Buying and Selling at Astera Labs
In other news, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $2,472,990.24. Following the transaction, the director directly owned 3,309 shares in the company, valued at $909,842.64. This trade represents a 73.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 220,497 shares of company stock valued at $62,043,303. Company insiders own 10.40% of the company’s stock.
About Astera Labs
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
See Also
- Five stocks we like better than Astera Labs
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
